Clinical TrialsSearch results
Number of results: 701
Other
- Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer.
- Colorectal cancer
- Japan Clinical Cancer Research Organization
- 2008-10-20
Other
- Phase II clinical trial of the first-line Stop-and-Go modified FOLFOX6 and bevacizmab for patients with unresectable/recurrent colorectal cancer
- colorectal cancer
- Mlnlstry of health, Labour and Welfare
- 2008-07-07
Other
- Multicenter PhaseII study of Combination FOLFIRI with Erbitux in advanced/metastatic colorectal cancer: EGFR positive and KRAS wild type
- Colorectal Cancer
- Epidemiological and Clinical Research Information Network (ECRIN)
- 2009-06-22
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- Clinical study to examine the effectiveness of Juzentaihoto in postoperative recovery for colorectal cancer patients - A research investigating the role of cell-mediated immunity in recovery
- Colorectal Cancer
- Sapporo Medical University School of Medicine First Department of Surgery
- 2008-07-08
Other
- Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
- colorectal cancer
- Tsukuba Cancer Clinical Trial Group
- 2008-12-03
Other
- A phase II study of 2nd-line FOLFIRI+aflibercept in patients with colorectal cancer resistant to anti-EGFR chemotherapy (HGCSG1801)
- colorectal cancer
- Komatsu Yoshito
- 2019-11-19
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01